Gts Securities LLC Esperion Therapeutics, Inc. Call Options Transaction History

Gts Securities LLC

  • $45.4 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$1.61 - $2.73 $65,849 - $111,657
-40,900 Reduced 79.26%
10,700 $17,000
Q2 2024

Aug 14, 2024
BUY
$1.84 - $3.24 $30,176 - $53,136
16,400 Added 46.59%
51,600 $114,000
Q1 2024

May 15, 2024
SELL
$2.02 - $3.02 $25,250 - $37,750
-12,500 Reduced 26.21%
35,200 $94,000
Q4 2023

Feb 14, 2024
BUY
$0.73 - $3.08 $34,821 - $146,916
47,700 New
47,700 $142,000

Others Institutions Holding ESPR

# of Institutions
208
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $160M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email